In a written statement here on Monday, PT Kimia Farma President Director Rusdi Rosman said the funds would be used to establish a raw medicinal material and health supplement factory in Lippo Cikarang, West Java.
The funds will also be used to set up a medicine factory in Banjaran, Bandung in West Java and the establishment of the second phase salt pharmacy factory in Batuwakon, Jombang of East Java and a diagnostic kit factory in Bali.
"In order to ensure that best medicines are made available for sale, we will build about new 125 drug stores and clinics in Indonesia with a budget of Rp150 billion to Rp200 billion," said Rusdi.
The PT Kimia Farma president director acknowledged that besides individual equity, the company will also be sourcing capital expenditure through syndicated assistance from a number of financial institutions to support Kimia Farmas expansion.
"We will probably prepare equity amounting to Rp200 billion to Rp250 billion. The rest will be managed through loans," he said.
A number of local and overseas banks are approaching Kimia Farma to provide loans. "We will, of course, avail of funds from a bank whose interest rate is the most competitive," he said.
Rusdi hoped that the income of PT Kimia Farma in 2015 would reach Rp5 trillion with a net profit of Rp250 billion. This year, it is expected to book an income of Rp5.6 trillion with a net profit of about five percent.
By 2015-end, Kimia Farma Drugstores had developed 725 drug store units scattered across Indonesia.
Apart from that, a total of 315 clinics, 42 clinics laboratories and other health facilities have been built. "In 2015, we had projected Kimia Farma Dispensary income at Rp3 trillion," Rusdi added.(*)
Editor: Heru Purwanto
Copyright © ANTARA 2016
